Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Ara-c 12 gm/m2 vs 18 gm/m2 in AML Consolidation
NCT01615757Phase 3Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine in acute myeloid leukemia (AML), sponsored by AIIMS New Delhi. Status: unknown.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01615757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615757.